Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-10-02
2007-10-02
Seaman, D. Margaret (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C546S157000
Reexamination Certificate
active
10889268
ABSTRACT:
The invention provides for compounds of formula Iwherein the substitutents are as described herein.Further provided are methods of using such compounds for the treatment of eating disorders, metabolic disorders, obesity, cognitive disorders, neurological disorders, pain disorders, inflammation disorders, in the promotion of smoking cessation and for the treatment of other psychiatric disorders Also provided are pharmaceutical compositions containing such compounds and pharmaceutical combinations of the compounds of the invention with other therapeutic agents.
REFERENCES:
patent: 4371720 (1983-02-01), Johnson et al.
patent: 5013387 (1991-05-01), Goodwin et al.
patent: 5081122 (1992-01-01), Ward
patent: 5292736 (1994-03-01), Kumar et al.
patent: 5403857 (1995-04-01), Edwards et al.
patent: 5773203 (1998-06-01), Kimura et al.
patent: 5891909 (1999-04-01), Soll et al.
patent: 5972961 (1999-10-01), Hewawasam et al.
patent: 6107252 (2000-08-01), Andree et al.
patent: 6541661 (2003-04-01), Delorme et al.
patent: 6559144 (2003-05-01), Diefenbach et al.
patent: 2001/0021709 (2001-09-01), Diefenbach et al.
patent: 2003/0232804 (2003-12-01), Pinto et al.
patent: 2004/0002495 (2004-01-01), Sher et al.
patent: 2004/0082798 (2004-04-01), Alonso-Alija et al.
patent: 044451 (1991-09-01), None
patent: 0570920 (1993-11-01), None
patent: 1340500 (2003-09-01), None
patent: 2735774 (1996-12-01), None
patent: 2272439 (1984-05-01), None
patent: WO94/12466 (1994-06-01), None
patent: WO96/36596 (1996-11-01), None
patent: WO97/29079 (1997-08-01), None
patent: WO98/41519 (1998-09-01), None
patent: WO99/02499 (1999-01-01), None
patent: WO 00/13508 (2000-03-01), None
patent: WO 01/79261 (2001-10-01), None
patent: WO 02/30357 (2002-04-01), None
patent: WO 02/070510 (2002-09-01), None
patent: WO 03/007887 (2003-01-01), None
patent: WO 03/020217 (2003-03-01), None
patent: WO 03/027069 (2003-04-01), None
patent: WO 03/027076 (2003-04-01), None
patent: WO 03/027114 (2003-04-01), None
patent: WO 03/035005 (2003-05-01), None
patent: WO 03/051850 (2003-06-01), None
patent: WO 03/051851 (2003-06-01), None
patent: WO 03/103677 (2003-12-01), None
patent: WO 2004/015130 (2004-02-01), None
Hewawasam, Bioorganic & Medicinal Chemistry Letters, vol. 12 (2002), pp. 1779-1783.
U.S. Appl. No. 10/889,274, filed Jul. 12, 2004, Sun et al.
Ewing William R.
Sher Philip M.
Sulsky Richard B.
Sun Chongqing
Wu Gang
Bristol--Myers Squibb Company
Duncan, Jr. Sammy G.
Gibbons Maureen S.
Seaman D. Margaret
LandOfFree
Tetrahydroquinoline derivatives as cannabinoid receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tetrahydroquinoline derivatives as cannabinoid receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetrahydroquinoline derivatives as cannabinoid receptor... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3853342